Dr. Martin A Kubiet MD

Recommended Articles

• What Complications May Occur If Bronchitis Goes Untreated?

  Acute bronchitis may not cause any complications if it occurs the first time in a person. It usually goes away by taking proper rest after about two to three weeks. However, if bronchitis is left untreated, it can affect the respiratory system and damage the airways and lungs. Because of this...

• Does Cystic Fibrosis Run in the Family?

  Cystic fibrosis is a disease affecting many people throughout the United States and the world. Yet, there is so much information out there that it is sometimes difficult to ascertain the most important facts. With this disease, you may have many lingering questions. How does someone get cystic...

• Becoming an Advocate for the Cystic Fibrosis Foundation

  The Cystic Fibrosis Foundation was founded in 1955 by a group of concerned parents who were determined to save their children’s lives. At the time, very little was known about cystic fibrosis and children with the disease were not expected to live past their elementary school years.However, thanks...

• Home Remedies for Pleurisy

  Pleurisy is the inflammation of the two membranes that line your lungs. Both your lungs are lined by a thin membrane called the pleura. One layer is lining your lungs and the other is lining the inside of your chest wall. Between these two membranes is a small cavity known as the pleural cavity. It...

• What Is Nicotine?

  IntroductionNicotine is an alkaloid stimulant that comes from the nightshade family of plants, particularly from the leaves of tobacco. The type of nicotine found in tobacco plants is called Nicotiana tabacum. Nicotine can also be synthetically produced. Thousands of chemicals are contained in...

• FDA Approves Orkambi to Treat Young Children with Cystic Fibrosis

  Orkambi is an oral drug developed by Vertex Pharmaceuticals and approved by the United States Food and Drug Administration (FDA) for the treatment of cystic fibrosis (CF) in certain patient groups. It is the second drug to be approved for use in patients with CF, after Kalydeco. ...